One important advances in medicine bring good news for patients with prostate cancer. Reported that survival for cancer patients is significantly better if it is irradiated to the standard hormone treatment.
The results were published Sunday of cancer yesterday at the conference. The study has the potential to develop ways of prostate treatment.
Approximately 20 percent of the nearly 200,000 people diagnosed with cancer that has spread attack to the area around the prostate.
"In this group, many patients eventually died of prostate cancer. Because of this condition is usually incurable, "said study leader Dr. Padraig Warde, an expert from the University of radiation
Toronto's Princess Margaret Hospital.
These people are treated with drugs that block testosterone, a hormone that helps the growth of prostate cancer. Although this treatment has been used for several decades, a new study conducted by involving 1,200 people who received radiation plus hormone or the hormone itself. After seven years, 74 percent of the men who received both treatments are still alive. Those who live in the two treatments on average six months longer than was given only hormone alone.
Serious side effects occurred in less than two percent of men in the group improved. This research was sponsored by the national Cancer Institute of Canada (National of Cancer Institute of Canada).
The results showed that "radiation is an indispensable element in the treatment of patients with high-risk prostate cancer," said Dr. Jennifer Obel, a cancer specialist at Northshore University Health System in Chicago who was not involved in this research.
Dr. Otis Brawley, medical director of the American Cancer Society, praised the increase in life expectancy by therapy, and he hoped that greater progress
0 comments:
Post a Comment